Quality Prescribing Strategy for Respiratory: A Guide for Improvement 2024-2027
(2024)
Report
Anderson, D., Fardon, T., Mair, A., Korsah, P., Smith, G., Strath, A., McMahon, A., & Leitch, J. (2024). Quality Prescribing Strategy for Respiratory: A Guide for Improvement 2024-2027
Outputs (49)
Medication without harm: policy brief (2024)
Report
Galappatthy, P., Mair, A., & Dhingra-Kumar, N. (2024). Medication without harm: policy brief. Geneva: World Health Organization
Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027 (2024)
Report
Mair, A., Kennon, B., Chalmers, J., Smith, G., Strath, A., McMahon, A., & Leitch, J. (2024). Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027. Scottish GovernmentThis quality prescribing guide is intended to support clinicians across the multidisciplinary team and people with Type 2 Diabetes Mellitus (T2DM) in shared decision-making and the effective use of medicines, and offers practical advice and options f... Read More about Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027.
Global burden of preventable medication-related harm in health care: a systematic review (2023)
Report
Panagioti, M., Hodkinson, A., Planner, C., Dhingra, N., & Gupta, N. (2023). Global burden of preventable medication-related harm in health care: a systematic review. Geneva: World Health Organization
Gaps in patient safety: Areas that need our attention (2023)
Journal Article
Wu, A. W., Vincent, C., Øvretveit, J., Mair, A., Buckle, P., Garcia Elorrio, E., Bellandi, T., Letaief, M., Ushiro, S., & Koizumi, S. (2023). Gaps in patient safety: Areas that need our attention. Journal of Patient Safety and Risk Management, 28(6), 246
Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023 (2023)
Journal Article
Alexander, G. C., Budnitz, D., Hughes, C., Maas, R., Mair, A., McDonald, E. G., Meid, A. D., Payne, R., Seidling, H. M., Shakir, S., Suissa, S., Tannenbaum, C., Schneeweiss, S., & Dreischulte, T. (2024). Proceedings of the International Ambulatory Drug SaMeeting report.
Optimizing polypharmacy management in the elderly: a comprehensive European benchmarking survey and the development of an innovative online benchmarking application (2023)
Journal Article
Kardas, P., Mair, A., Stewart, D., & Lewek, P. (2023). Optimizing polypharmacy management in the elderly: a comprehensive European benchmarking survey and the development of an innovative online benchmarking application. Frontiers in Pharmacology, 14, ArtBackground: Polypharmacy, defined as the simultaneous use of multiple medications by a patient, is a worldwide problem of rising prevalence. Paving the way for drug interactions, adverse drug reactions and non-adherence, it leads to negative health o... Read More about Optimizing polypharmacy management in the elderly: a comprehensive European benchmarking survey and the development of an innovative online benchmarking application.
Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper (2023)
Journal Article
van Poelgeest, E., Seppala, L., Bahat, G., Ilhan, B., Mair, A., van Marum, R., …van der Velde, N. (2023). Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology posiKey summary points: Aim: To summarize the literature on medication review and deprescribing in older adults, and formulate recommendations to improve prescribing medications in older, multimorbid adults with polypharmacy. Findings: Current evidence d... Read More about Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper.
Medication safety for look-alike, sound-alike medicines (2023)
Report
Galappatthy, P., Mair, A., Dhingra-Kumar, N., Häkkinen-Wu, M., Taha, A., & Takanashi, F. (2023). Medication safety for look-alike, sound-alike medicines. Geneva: World Health Organization
iSIMPATHY Evaluation Report (2023)
Book
Mair, A., Kirke, C., Scott, M., Michael, N., Kanan, Y., Law, S., Scullin, C., Fleming, G., Hyder Skinner, N., & Kyle, D. (2023). iSIMPATHY Evaluation Report
Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes (2023)
Journal Article
Urbańczyk, K., Guntschnig, S., Antoniadis, V., Falamic, S., Kovacevic, T., Kurczewska-Michalak, M., …Kardas, P. (2023). Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improClinical pharmacy as an area of practice, education and research started developing around the 1960s when pharmacists across the globe gradually identified the need to focus more on ensuring the appropriate use of medicines to improve patient outcome... Read More about Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes.
Evidence of the Impact of Interventions to Decrease Polypharmacy (2023)
Book Chapter
Mair, A. (2023). Evidence of the Impact of Interventions to Decrease Polypharmacy. In Encyclopaedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy. Springer. https://doi.org/10.1007/978-3-030-50247-8_146-1As many as 50% of all patients with long-term conditions are using their medicines in a way that is not fully effective. This results in suboptimal treatment of their condition and attendance or admission to hospital. There is a significant level of... Read More about Evidence of the Impact of Interventions to Decrease Polypharmacy.
Polypharmacy and Integrated Care (2021)
Book Chapter
Mair, A., & Alonso, A. (2021). Polypharmacy and Integrated Care. In V. Amelung, V. Stein, E. Suter, N. Goodwin, E. Nolte, & R. Balicer (Eds.), Handbook Integrated Care (453-477). Cham: Springer. https://doi.org/10.1007/978-3-030-69262-9_27Safe and effective pharmacological treatment remains one of the greatest challenges in medicine, where models of healthcare delivery lag behind the enormous growth in single disease focused treatment with medicines. The implications for safe, efficie... Read More about Polypharmacy and Integrated Care.
Appropriate polypharmacy: a barometer for integrated care (2020)
Journal Article
Mair, A., Antoniadou, E., Hendry, A., & Gabrovec, B. (2021). Appropriate polypharmacy: a barometer for integrated care. Journal of Integrated Care, 29(2), 204-214. https://doi.org/10.1108/jica-04-2020-0019Purpose Polypharmacy, the concurrent use of multiple medicines by one individual, is a common and growing challenge driven by an ageing population and the growing number of people living longer with chronic conditions. Up to 11% of unplanned hospita... Read More about Appropriate polypharmacy: a barometer for integrated care.
Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials (2020)
Journal Article
Pazan, F., Petrovic, M., Cherubini, A., Onder, G., Cruz-Jentoft, A. J., Denkinger, M., …Wehling, M. (2021). Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic reviewBackground Frailty and adverse drug effects are linked in the fact that polypharmacy is correlated with the severity of frailty; however, a causal relation has not been proven in older people with clinically manifest frailty. Methods A literatur... Read More about Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials.
Addressing the Challenge of Polypharmacy (2019)
Journal Article
Mair, A., Wilson, M., & Dreischulte, T. (2020). Addressing the Challenge of Polypharmacy. Annual Review of Pharmacology and Toxicology, 60(1), 661-681. https://doi.org/10.1146/annurev-pharmtox-010919-023508Polypharmacy describes the concomitant use of multiple medicines and represents a growing global challenge attributable to aging populations with an increasing prevalence of multimorbidity. Polypharmacy can be appropriate but is problematic when the... Read More about Addressing the Challenge of Polypharmacy.
Quality Prescribing for Chronic Pain: A Guide for Improvement (2019)
Report
Chronic Pain Expert group, , & Scottish Government, . (2019). Quality Prescribing for Chronic Pain: A Guide for Improvement. Edinburgh: Scottish Government
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases (2019)
Journal Article
Bousquet, J. J., the ARIA Study Group, Schünemann, H. J., Togias, A., Erhola, M., Hellings, P. W., …the MASK Study Group. (2019). Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases. Clinical and TranslaBackground In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the healt... Read More about Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases.
The polypharmacy programme in Scotland: realistic prescribing (2019)
Journal Article
Mair, A., Wilson, M., & Dreischulte, T. (2019). The polypharmacy programme in Scotland: realistic prescribing. Prescriber, 30(8), 10-16. https://doi.org/10.1002/psb.1779Since 2012, NHS Scotland has published a series of polypharmacy guidelines to help clinicians address the many medication‐related problems arising from multimorbidity. Here, Alpana Mair, Chair of the guideline group, Martin Wilson and Tobias Dreischu... Read More about The polypharmacy programme in Scotland: realistic prescribing.
Medication safety in polypharmacy: technical report (2019)
Report
Mair, A. (2019). Medication safety in polypharmacy: technical report. Geneva: WHOAs the population ages more people are likely to suffer from multiple long term illness and take multiple medications. It is essential to therefore take a person-centred approach to ensure that the medications are appropriate for the individual to ga... Read More about Medication safety in polypharmacy: technical report.
Medication Safety in Transitions of Care: Technical Report (2019)
Report
World Health Organisation. (2019). Medication Safety in Transitions of Care: Technical Report. Geneva: WHOMedication discrepancies impact almost every patient that moves across transitions of care, e.g. admission to or discharge from hospital. WHO urges countries to prioritise early and sustained action to reduce medication-related harm arising at transi... Read More about Medication Safety in Transitions of Care: Technical Report.
Medication Safety in High Risk Situations (2019)
Report
World Health Organization. (2019). Medication Safety in High Risk Situations. Geneva: World Health Organization
Polypharmacy and pharmacovigilance: How they relate and why it matters (2019)
Journal Article
Mair, A. (2019). Polypharmacy and pharmacovigilance: How they relate and why it matters. Uppsala Reports, 80, 12-13Patients with multiple medical conditions – and, consequently, needing multiple medications – present one of the greatest challenges currently facing health services.
ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy”: AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé), POLLAR (Impact of Air POLLution on Asthma and Rhinitis), GARD Demonstration project (2019)
Journal Article
Bosnic‐Anticevich, S., Costa, E., Menditto, E., Lourenço, O., Novellino, E., Bialek, S., …Bousquet, J. (2019). ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy”: AIRWAYS ICPs initiative (European Innovation Partnership oPharmacists are trusted health care professionals. Many patients use over‐the‐counter (OTC) medications and are seen by pharmacists who are the initial point of contact for allergic rhinitis management in most countries. The role of pharmacists in in... Read More about ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy”: AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé), POLLAR (Impact of Air POLLution on Asthma and Rhinitis), GARD Demonstration project.
Age-Related Medicine (2019)
Journal Article
Wahlich, J., Orlu, M., Mair, A., Stegemann, S., & van Riet-Nales, D. (2019). Age-Related Medicine. Pharmaceutics, 11(4), Article 172. https://doi.org/10.3390/pharmaceutics11040172A meeting organised by the Academy of Pharmaceutical Sciences focussed on the challenges of developing medicines for older adults. International experts discussed the complexity introduced by polypharmacy and multiple morbidities and how the risk–ben... Read More about Age-Related Medicine.
Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study (2019)
Journal Article
Sheikh, A., De Vries, G., Anto, J. M., Annesi‐Maesano, I., Wickman, M., Hellings, P. W., …Menditto, E. (2019). Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study. Clinical and Experimental AllergyBackground Mobile technology may help to better understand the adherence to treatment. MASK‐rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient‐centred ICT system. A mobile phone app (the Allergy Diary) central to MASK is a... Read More about Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study.
EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research (2019)
Journal Article
Seppala, L. J., van der Velde, N., Masud, T., Blain, H., Petrovic, M., van der Cammen, T. J., …the EuGMS Special Interest Group on Pharmacology. (2019). EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge DisseminatiFalls are a major public health concern in the older population, and certain medication classes are a significant risk factor for falls. However, knowledge is lacking among both physicians and older people, including caregivers, concerning the role o... Read More about EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research.
Quality Prescribing for Diabetes: A Guide for Improvement (2018)
Report
Diabetes Expert Working Group, , & Scottish Government, . (2018). Quality Prescribing for Diabetes: A Guide for Improvement. Edinburgh: Scottish Government
Quality Prescribing for Respiratory: A Guide for Improvement (2018)
Report
Respiratory Expert Group, , & Scottish Government, . (2018). Quality Prescribing for Respiratory: A Guide for Improvement. Edinburgh: Scottish Government
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology (2018)
Journal Article
Bousquet, J., Hellings, P. W., Agache, I., Amat, F., Annesi-Maesano, I., Mair, A., & Mobile Airways Sentinel Network (MASK) Study Group, . (2019). Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis andAllergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase o... Read More about Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology.
Polypharmacy Guidance: Realistic Prescribing. 3rd edition (2018)
Report
Scottish Government Polypharmacy Model of Care Group, . (2018). Polypharmacy Guidance: Realistic Prescribing. 3rd edition. Edinburgh: Scottish Government
A case study of polypharmacy management in nine European countries: Implications for change management and implementation (2018)
Journal Article
McIntosh, J., Alonso, A., MacLure, K., Stewart, D., Kempen, T., Mair, A., …on behalf of the SIMPATHY Consortium. (2018). A case study of polypharmacy management in nine European countries: Implications for change management and implementation. PLOS ONE,Background Multimorbidity and its associated polypharmacy contribute to an increase in adverse drug events, hospitalizations, and healthcare spending. This study aimed to address: what exists regarding polypharmacy management in the European Union (... Read More about A case study of polypharmacy management in nine European countries: Implications for change management and implementation.
A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management of polypharmacy in older people (2017)
Journal Article
Stewart, D., Gibson-Smith, K., MacLure, K., Mair, A., Alonso, A., Codina, C., …Wiese, B. (2017). A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management ofBackground Inappropriate use of multiple medicines (inappropriate polypharmacy) is a major challenge in older people with consequences of increased prevalence and severity of adverse drug reactions and interactions, and reduced medicines adherence.... Read More about A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management of polypharmacy in older people.
Medication review and polypharmacy management in the hospital setting. The cases of Greece and Catalonia (2017)
Presentation / Conference Contribution
Gennimata, D., Kampolis, C. F., Vontetsianos, T., Mcintosh, J., Codina, C., Alonso, A., & Mair, A. (2017). Medication review and polypharmacy management in the hospital setting. The cases of Greece and Catalonia. International journal of integrated care,Introduction: Medication review and polypharmacy management, especially in the elderly, are key components of integrated care. Although polypharmacy management is often associated with the primary care setting, hospital clinicians, who are often memb... Read More about Medication review and polypharmacy management in the hospital setting. The cases of Greece and Catalonia.
Sustainable Implementation of Polypharmacy reviews as part of integrated care at Scale (2017)
Presentation / Conference Contribution
Mair, A. R., Kinnear, M., Hurding, S., Micheal, N., & Wilson, M. (2017). Sustainable Implementation of Polypharmacy reviews as part of integrated care at Scale. International journal of integrated care, 17(5), Article A485. https://doi.org/10.5334/ijic.38Medication is the most common form of intervention to prevent disease or slow disease progression, with guidelines for single diseases recommending evidence based drug treatments. There remains the mismatch between prescribing guidelines for speci... Read More about Sustainable Implementation of Polypharmacy reviews as part of integrated care at Scale.
Polypharmacy management by 2030: A patient safety challenge (2017)
Report
Mair, A., Fernandez-Llimos, F., Alonso, A., Harrison, C., Hurding, S., Kempen, T., …The SIMPATHY consortium. (2017). Polypharmacy management by 2030: A patient safety challenge. Coimbra: European Commission
Increasing adherence in therapies and polypharmacy in Europe: EIP on AHA Action Group A1 activities toward integrated care information systems and self-management applications (2016)
Journal Article
Fico, G., Cena, C., Mair, A., Monaco, A., Costa, E., Giardini, A., & Papadopoulos, H. (2016). Increasing adherence in therapies and polypharmacy in Europe: EIP on AHA Action Group A1 activities toward integrated care information systems and self-managemenNo abstract available.
Polypharmacy management programmes: the SIMPATHY Project (2016)
Journal Article
Fernandez-Llimos, F., & Mair, A. (2017). Polypharmacy management programmes: the SIMPATHY Project. European Journal of Hospital Pharmacy, 24(1), 5-6. https://doi.org/10.1136/ejhpharm-2016-001044No abstract available.
The use of PESTEL as a change management tool to inform change management of polypharmacy and adherence within SIMPATHY program (2016)
Presentation / Conference Contribution
Geitona, M., Vontetsianos, T., Mair, A., Mc Kenzie, D., Michael, N., Kousoulakou, H., …Balasopoulou, A. (2016). The use of PESTEL as a change management tool to inform change management of polypharmacy and adherence within SIMPATHY program. InternationaIntroduction: Polypharmacy and medication adherence in the older populationwith multiple chronic conditionsare significant public health issues across all the European Union (EU) countries. SIMPATHY (Stimulating Innovation Management of Polypharmacy... Read More about The use of PESTEL as a change management tool to inform change management of polypharmacy and adherence within SIMPATHY program.
Polypharmacy and Adherence: Key Components of Integrated Care Findings from the SIMPATHY Project (2016)
Presentation / Conference Contribution
Mair, A., McIntosh, J., Codina, C., Molist, N., & Alonso, A. (2016). Polypharmacy and Adherence: Key Components of Integrated Care Findings from the SIMPATHY Project. International journal of integrated care, 16(6), A190. https://doi.org/10.5334/ijic.2738Context, aims and objectives: As many as half of all patients with chronic conditions are using their medicines in a way that is not fully effective, resulting in sub-optimal treatment and subsequent increases in hospitalisations and emergency depart... Read More about Polypharmacy and Adherence: Key Components of Integrated Care Findings from the SIMPATHY Project.
Guidance to manage inappropriate polypharmacy in older people: systematic review and future developments (2016)
Journal Article
Lewek, P., MacLure, K., McIntosh, J., Alonso, A., Kardas, P., Wilson, M., …Stewart, D. (2016). Guidance to manage inappropriate polypharmacy in older people: systematic review and future developments. Expert Opinion on Drug Safety, 16(2), 203-213. httpsIntroduction: Single disease state led evidence-based guidelines do not provide sufficient coverage of issues of multimorbidities, with the cumulative impact of recommendations often resulting in overwhelming medicines burden. Inappropriate polypharm... Read More about Guidance to manage inappropriate polypharmacy in older people: systematic review and future developments.
Polypharmacy management: an under recognized public health issue (2016)
Presentation / Conference Contribution
McIntosh, J., Alonso, A., Codina, C., & Mair, A. (2016). Polypharmacy management: an under recognized public health issue. European Journal of Public Health, 26(suppl_1), https://doi.org/10.1093/eurpub/ckw174.050Background Multiple chronic diseases in individuals increase the risk of inappropriate polypharmacy, an under recognised public health issue. SIMPATHY (Stimulating Innovation Management of Polypharmacy and Adherence in The Elderly) aims to develop c... Read More about Polypharmacy management: an under recognized public health issue.
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (2016)
Journal Article
Bousquet, J., Farrell, J., Crooks, G., Hellings, P., Bel, E. H., Bewick, M., …Mercier, J. (2016). Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: AreAction Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respir... Read More about Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).
Prescribing to fit the needs of older people – the NHS Scotland Polypharmacy Guidance, 2nd edition (2015)
Journal Article
Wilson, M., Mair, A., Dreischulte, T., & Witham, M. (2015). Prescribing to fit the needs of older people – the NHS Scotland Polypharmacy Guidance, 2nd edition. Journal of the Royal College of Physicians of Edinburgh, 45(2), 108-113. https://doi.org/10.4
Polypharmacy: Manage Medicines App (2015)
Digital Artefact
Mair, A. (2015). Polypharmacy: Manage Medicines App. [App]
Integrated care pathways for airway diseases (AIRWAYS-ICPs) (2014)
Journal Article
Bousquet, J., Addis, A., Adcock, I., Agache, I., Agusti, A., Alonso, A., …Zuberbier, T. (2014). Integrated care pathways for airway diseases (AIRWAYS-ICPs). European Respiratory Journal, 44(2), 304-323. https://doi.org/10.1183/09031936.00014614
Prescription For Excellence (2013)
Report
Scottish Government. (2013). Prescription For Excellence. Edinburgh: Scottish GovernmentPolicy document setting out the vision for pharmacy. A vision and action plan for the future of NHS pharmaceutical care in Scotland through integrated partnerships and innovation.
Cochrane EPOC Protocol Providing medication adherence feedback to healthcare providers. The effect on care and outcomes. Protocol for a Cochrane review update Authors
Preprint / Working Paper
Hassett, R., Sabatier, B., Savoldelli, V., Mair, A., Hanley, J., Dima, A., & Paterson, R. (2022). Cochrane EPOC Protocol Providing medication adherence feedback to healthcare providers. The effect on care and outcomes. Protocol for a Cochrane review updatThis is a protocol for a Cochrane Review (update). Background Key barriers to effectively supporting adherence include poor awareness amongst healthcare professionals (HCPs), scarce clinical tools and interventions, and suboptimal patient-provide... Read More about Cochrane EPOC Protocol Providing medication adherence feedback to healthcare providers. The effect on care and outcomes. Protocol for a Cochrane review update Authors.
Prescribing and Safety Monitoring in Elderly Care
Book Chapter
Mair, A., Mair, A., Hilmer, S., & Kouladjian O’Donnell, L. (in press). Prescribing and Safety Monitoring in Elderly Care. In Pharmacovigilance and Drug Safety in Clinical Practice. Springer